Skip to main content
. 2021 May 2;142(1):159–177. doi: 10.1007/s00401-021-02317-z

Fig. 2.

Fig. 2

W-Tau antibody validation and protein expression in human brain. a Immunoprecipitation assay of HEK239T cells overexpressing W-T30 using W-Tau (Abyntek) or total Tau (NOVUSBIO, NB100-82247) antibodies and Western blot detection of immunoprecipitated Tau using 7.51 antibody. b Immunoprecipitation of the same cells overexpressing W-T30 and control untransfected cells using W-Tau antibody and detection of immunoprecipitated Tau using total Tau (Tau 7.51) antibody. c HEK293T cells were transfected with eukaryotic expression vectors empty or encoding different MAPT isoforms (T42, T30, W-T42, W-T30, ET-42 and ET-T30). Representative Western Blot for Tau 7.51 and W-Tau antibodies proving W-Tau specificity. d Western blot detection of W-Tau in frontal lateral cortex and hippocampus of one human subject that show bands at 50 kDa (W-T42), 38 KDa (W-T30), and 31 KDa (W-Tau truncated). e Representative Western blot of frontal lateral cortex and hippocampus samples of the same three human subjects (a, b, c) showing the presence of W-Tau and total Tau (Tau5)